Pyronaridine‐artesunate (PY‐AS) vs mefloquine plus artesunate (MQ + AS)
Total failure: day 28 (unadjusted) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) probably leads to lower total failure: day 28 (unadjusted) compared with mefloquine plus artesunate (MQ + AS) (moderate certainty).
2 findings from 1 review
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 0.36 [0.17, 0.78]1 study · 1120 participantsModerate
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 0.84 [0.54, 1.31]1 study · 1059 participantsLow